Research and Development Department, Novagli Pharma SAS, Evry Cedex, France.
Cornea. 2013 Mar;32(3):345-54. doi: 10.1097/ICO.0b013e31825e83f4.
The aim of this study was to compare the ocular and systemic distribution of cyclosporine A (CsA) in rabbits after the instillation of preservative-free CsA cationic and anionic emulsions.
For the single-dose pharmacokinetic (PK) study, rabbits were instilled with 50 μL of the test material. For the multiple-dose PK study, rabbits were instilled twice daily with Restasis or once daily with NOVA22007 for 10 days. At each time point, the cornea, conjunctiva, and whole blood were harvested for CsA quantification. Ocular and systemic distribution were determined after 4 times daily instillations with 50 μL of 3H-CsA cationic and anionic emulsions for 7 days. Restasis was used as a reference in all studies.
Single-dose PK data demonstrated that NOVA22007 0.1% and 0.05% delivered higher CsA concentrations to the cornea than Restasis [concentration maximum (C max): 2692, 1372, and 748 ng/g, respectively] and have a better exposition (area under the curve). Conjunctival Cmax values were 1914, 696, and 849 ng/g and area under the curve values were 3984, 2796, and 2515 ng/g · h, for either dose of the cationic emulsions and Restasis, respectively. The multiple-dose PK and the 3H-CsA distribution data demonstrated that the systemic distribution after repeated instillations was low and comparable for all emulsions.
These data demonstrate that the CsA cationic emulsions were more effective than Restasis at delivering CsA to target tissues, thus confirming the potential advantage of cationic emulsions over anionic emulsions as vehicle for ocular drug delivery for the treatment of ocular surface diseases.
本研究旨在比较滴眼给予无防腐剂环孢素 A(CsA)阳离子和阴离子乳剂后,CsA 在兔眼内和全身的分布。
对于单次剂量药代动力学(PK)研究,给兔眼内滴注 50μL 试验材料。对于多次剂量 PK 研究,给兔每日 2 次滴注 Restasis 或每日 1 次滴注 NOVA22007,共 10 天。在每个时间点,采集角膜、结膜和全血以定量 CsA。在每日 4 次滴注 50μL 3H-CsA 阳离子和阴离子乳剂 7 天后,测定眼内和全身分布。在所有研究中,均将 Restasis 作为参比制剂。
单次剂量 PK 数据表明,NOVA22007 0.1%和 0.05%的角膜 CsA 浓度高于 Restasis [浓度峰值(C max):分别为 2692、1372 和 748ng/g],暴露度(曲线下面积)更好。阳离子乳剂各剂量组和 Restasis 的结膜 C max 值分别为 1914、696 和 849ng/g,曲线下面积值分别为 3984、2796 和 2515ng/g·h。多次剂量 PK 和 3H-CsA 分布数据表明,重复滴眼后的全身分布较低,所有乳剂之间具有可比性。
这些数据表明,CsA 阳离子乳剂比 Restasis 更有效地将 CsA 递送至靶组织,从而证实阳离子乳剂作为眼部药物传递载体用于治疗眼表疾病的潜在优势超过阴离子乳剂。